logo

FDA Calendar

Share
PDUFA dates and FDA Panel Review dates are very important because they are make or break events for biostocks when the decisions are announced. Also, usually biostocks experience a run-up going into the scheduled decision/review dates. So having prior knowledge of the catalysts goes a long way toward maximizing profit or minimizing loss while trading volatile biotech stocks.
Listed below are large cap, mid cap and small cap stocks with pending regulatory catalysts.

Get in-depth analysis and insight on investing in the high-stakes biotech and pharma sectors. Check out our premium biotech research product and our biotech home page.
Company Name
Ticker
Drug
Event
Date
Outcome
Details
Verrica Pharmaceuticals Inc.
VP-102 (cantharidin 0.7% Topical Solution) (NDA)
FDA decision on VP-102 for the Treatment of Molluscum Contagiosum
07/13/2020
Endo International plc
Collagenase clostridium histolyticum (BLA)
FDA decision on collagenase clostridium histolyticum (CCH) for cellulite in buttocks
07/06/2020
GlaxoSmithKline PLC
GSK.L, GSK
Belantamab mafodotin (BLA)
FDA decision on Belantamab mafodotin for the treatment of patients with relapsed or refractory multiple myeloma
06/19/2020
Evoke Pharma, Inc.
GimotI (NDA resubmission)
FDA decision on Gimoti for the relief of symptoms in adult women with acute and recurrent diabetic gastroparesis.
06/19/2020
Viela Bio
Inebilizumab (BLA)
FDA decision on Inebilizumab the treatment of neuromyelitis optica spectrum disorder
06/11/2020
Viela Bio
Inebilizumab (BLA)
FDA decision on Inebilizumab for treatment of patients with neuromyelitis optica spectrum disorder (
06/11/2020
Foamix Pharmaceuticals Ltd.
FMX103 topical foam (NDA)
FDA decision on FMX103 for the treatment of moderate-to-severe papulopustular rosacea in adults.
06/02/2020
Immunomedics Inc.
Sacituzumab Govitecan (Resubmission BLA)
FDA decision on Sacituzumab Govitecan for patients with Metastatic Triple-Negative Breast Cancer
06/02/2020
Incyte Corporation
Pemigatinib (NDA)
FDA decision on Pemigatinib for patients with locally advanced or metastatic cholangiocarcinoma with FGFR2 fusions
05/30/2020
PTC Therapeutics Inc.
Risdiplam (NDA)
FDA decision on Risdiplam for the treatment of spinal muscular atrophy
05/24/2020
Roche Holding AG
Risdiplam (NDA)
FDA decision on risdiplam for spinal muscular atrophy
05/24/2020
Sumitomo Dainippon Pharma
Dasotraline (NDA)
FDA decision on Dasotraline for the treatment of patients with moderate-to-severe binge eating disorder
05/14/2020
Halozyme Therapeutics, Inc.
DARZALEX (BLA)
FDA decision on subcutaneous delivery of DARZALEX for patients with multiple myeloma.
05/12/2020
Sanofi
Isatuximab (BLA)
FDA decision on Isatuximab b for the treatment of patients with relapsed/refractory multiple myeloma
04/30/2020
United Therapeutics Corp
Trevyent (UTHR)
FDA decision on Trevyent for the treatment of pulmonary arterial hypertension
04/27/2020
Buy this Content


pharma-071417_22jan20.jpg Today's Daily Dose brings you news about Akcea's promising trial results of antisense drug AKCEA-APOCIII-LRx, Applied Genetic's upcoming event, the near-term catalyst of Baudax Bio and Sierra Oncology's reverse stock split.
pharma-071717_21jan20.jpg Today's Daily Dose brings you news about the update on Evoke Pharma's resubmitted New Drug Application for Gimoti; FDA's Fast Track Designation for Genprex' investigational immunogene therapy Oncoprex and Horizon Therapeutics securing FDA approval of TEPEZZA for the treatment of Thyroid Eye Disease, among others.
fdadecision-jan21.jpg Shares of Epizyme Inc. (EPZM) have gained nearly 10 percent over the last 1 week as the Company awaits the FDA decision on its New Drug Application for Tazemetostat, slated to be announced on January 23, 2020.
Read More
Australia-based medicinal cannabis company Creso Pharma has intensified its focus on animal health, saying it plans to launch two additional hemp-derived products this year to improve the well-being of pets. Creso Pharma hopes to continue leveraging the rising global trend of the 'humanisation' of...
California is planning to use QR codes to identify illicit cannabis businesses and sales in the state. The California Bureau of Cannabis Control on Thursday proposed emergency regulations that would make it mandatory for licensed cannabis businesses in the state to post their unique Quick Response...
Canadian cannabis-infused product maker Olli Brands Inc. said it has joined hands with recreational cannabis brand Ace Valley in a private label partnership to create Ace Valley-branded, cannabis-infused gummies. The Ace Valley Gummies will be made with real fruit. It will be gluten-free as well...
Read More
>